A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to see how it compared to a one-time antibody injection ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

The FDA has given the green light to expand the use of Moderna's vaccine for the treatment of RSV, the virus that causes ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new antibody treatment ...

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.

On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.